Recent Articles
Atossa Therapeutics Stock Lost Its Covid Mojo, and Its Pipeline Fails To Impress
Atossa’s COVID-19 treatment is too little too late and I am concerned about the market size for Endoxiden. ATOS stock should not have a $448 million market cap.
With ContextLogic Stock Selling At Bargain Prices, Buy for the Long-Term
WISH stock is selling at a discount due to Wall Street aggressively slashing price targets. ContextLogic still has the potential to be a major player in e-commerce.
Nano Dimension Is a Solid Pick Now Selling at a Discount
Nano Dimension’s DragonFly system could usher in a new golden age of manufacturing. NNDM stock is a compelling long-term opportunity.
General Electric Is a Solid Bet on the Economic Recovery
General Electric management recently raised its cash flow expectations after a great quarter. It should see a sizeable boost to its price.
AirBnb Stock Is Still Poised To Benefit From a Travel Rebound
Negative sentiment is dampening ABNB stock. However, Airbnb has proven that it can thrive in a post-COVID travel industry
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.
